R&D Can China’s biotech industry weather frosty US relations? The Chinese biotech industry has grown rapidly to become a major hub of research.
Views & Analysis US loses, EU wins as Chinese biotech investment shifts focus Chinese biotech investors are taking an interest in the European market as diplomatic relations with the US become strained.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
